Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practice parameters for sublingual immunotherapy.

C Ortolani1, F Agostinis, S Amoroso

  • 1Casa di Cura Ambrosiana, Cesano Boscone, Milan, Italy.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|May 17, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?

Allergy·2026
Same author

Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registry.

European annals of allergy and clinical immunology·2025
Same author

Pollen-induced asthma: a unique model of mild to moderate asthma.

European annals of allergy and clinical immunology·2025
Same author

Pollen-induced asthma: diagnostic and therapeutic implications.

European annals of allergy and clinical immunology·2025
Same author

Pollen-induced asthma: a specific pheno-endotype of disease?

European annals of allergy and clinical immunology·2025
Same author

Plesiomonas shigelloides infection in newborn: case report and literature review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2024
Same journal

Spirometry after treatment completion for pulmonary tuberculosis - a necessity?

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Heart failure at the crossroads of climate change and environmental health: emerging risks, mechanistic insights, and future directions.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Aspiration pneumonia in stroke survivors: prevalence and clinical associations at Bolan Medical Complex.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

The silent fractures: unmasking osteoporosis in south Indian chronic obstructive pulmonary disease patients.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

Vitamin D deficiency in patients with tuberculosis: prevalence, risk factors and treatment outcomes.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same journal

A correlational study to assess the levels of adherence to treatment, illness perception and acceptance of illness in patients with coronary artery disease attending the outpatient departments at a tertiary care hospital.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
See all related articles
This summary is machine-generated.

Sublingual immunotherapy (SLIT) is effective for allergic rhinoconjunctivitis and asthma. This evidence-based guideline details SLIT indications, administration, and duration for optimal patient outcomes.

Area of Science:

  • Allergy and Immunology
  • Clinical Practice Guidelines
  • Immunotherapy

Background:

  • Sublingual immunotherapy (SLIT) efficacy and safety are established through clinical trials and post-marketing data.
  • A panel of Italian specialists developed practice parameters for SLIT based on evidence-based criteria.

Purpose of the Study:

  • To propose practice parameters for the clinical use of sublingual immunotherapy (SLIT).
  • To provide evidence-based recommendations for SLIT indications, administration, and duration.

Main Methods:

  • Review of clinical trials, meta-analyses, and post-marketing surveys.
  • Consensus development by a panel of Italian specialists.
  • Application of evidence-based criteria for grading recommendations.

Related Experiment Videos

Main Results:

  • SLIT is indicated for allergic rhinoconjunctivitis, asthma, and conjunctivitis (Grade A).
  • Recommended for moderate/severe rhinitis and mild/moderate asthma (Grade D).
  • Safe for children 3-5 years (Grade B) and adults over 60 (Grade D).
  • Allergen selection combines clinical history and skin prick tests (Grade D).
  • Polysensitization does not preclude SLIT (Grade D).
  • Continuous schedules recommended for perennial allergens; pre-co-seasonal for short pollination (Grades D, C).
  • Build-up phases are safe but modifiable (Grades A, C).
  • 3-5 years of SLIT duration recommended for long-lasting effects (Grade C).

Conclusions:

  • SLIT is a safe and effective treatment option for allergic diseases.
  • These guidelines provide a framework for optimal SLIT implementation.
  • Long-term treatment duration is crucial for sustained clinical benefit.